Importantly, these tumor-derived GPs were shown to mirror the transcriptional profile of GPs isolated from IRF8−/− mice compared to those of the non-tumor-bearing controls, lending further evidence that the loss of IRF8 expression during granulopoieses skews myeloid differentiation toward PMN-MDSCs. The gene discussed is IRF8; the disease is neoplasm.